Literature DB >> 12526723

Bupropion poisoning: a case series.

Corrine R Balit1, Christa N Lynch, Geoffrey K Isbister.   

Abstract

OBJECTIVE: To investigate the toxicity of bupropion hydrochloride in deliberate self-poisoning in adults and accidental ingestion by children. DESIGN AND
SETTING: Prospective study of cases identified from calls to the New South Wales Poisons Information Centre (NSW PIC), with follow-up through hospital medical records. PARTICIPANTS: Patients with bupropion poisoning managed in hospital, about whom the NSW PIC was contacted for advice, from 1 November 2000 to 31 July 2001 (59 adults and 10 children). MAIN OUTCOME MEASURES: Clinical effects, adverse outcomes (including seizures and death) and treatment.
RESULTS: 45 of the 59 adults were followed up (76%), 19 of whom had taken bupropion alone. Major clinical effects of bupropion included sinus tachycardia (83%), hypertension (56%), seizures (37%), gastrointestinal symptoms (37%) and agitation (32%). Seizures were dose-dependent, with those having seizures ingesting a significantly higher median dose (P = 0.02). All seizures were brief and self-limiting. 29 patients received decontamination therapy. 10 patients required pharmacological sedation, 10 were admitted to intensive care and six were intubated. None died. Eight of 10 accidental ingestions by children were followed up (80%); one child had symptoms (vomiting and hallucinations).
CONCLUSIONS: Bupropion overdose caused significant clinical effects in adults, but few in children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526723     DOI: 10.5694/j.1326-5377.2003.tb05064.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  10 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Fatal bupropion overdose with post mortem blood concentrations.

Authors:  Henry A Spiller; Edward Bottei; Linda Kalin
Journal:  Forensic Sci Med Pathol       Date:  2007-08-22       Impact factor: 2.007

Review 3.  Cardiovascular effects of antiobesity drugs: are the new medicines all the same?

Authors:  Mauro Cataldi; Angelo Cignarelli; Francesco Giallauria; Giovanna Muscogiuri; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2020-07-20

4.  The outcome of unintentional pediatric bupropion ingestions: a NPDS database review.

Authors:  Michael C Beuhler; Henry A Spiller; Howell C Sasser
Journal:  J Med Toxicol       Date:  2010-03

5.  Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.

Authors:  Marie-Nöelle Beyens; Claire Guy; Genevieve Mounier; Sylvie Laporte; Michel Ollagnier
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Seizures after overdoses of bupropion intake.

Authors:  Hasan Kara; Ahmet Ak; Ayşegül Bayır; Demet Acar; Rabia Istanbulluoğlu; Selim Değirmenci
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

Review 7.  Consensus statements on the clinical understanding and use of bupropion in Hong Kong.

Authors:  Wing-King Lee; Kwok-Leung Au Yeung; Ho-Bun Lam; Chi-Keung Wong; Ting-Chi Wong; Chi-Kin Fu; Shiu-Kow Sham; Ming-Kai Au; Tat-Chung Lam; Daniel Ki-Yan Mak
Journal:  CNS Neurosci Ther       Date:  2021-03       Impact factor: 5.243

Review 8.  Psychological and Psychopharmacological Interventions in Psychocardiology.

Authors:  Kai G Kahl; Britta Stapel; Christoph U Correll
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

9.  Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride.

Authors:  Peter H Silverstone; Robert Williams; Louis McMahon; Rosanna Fleming; Siobhan Fogarty
Journal:  Ann Gen Psychiatry       Date:  2008-08-18       Impact factor: 3.455

10.  Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice.

Authors:  Peter H Silverstone; Robert Williams; Louis McMahon; Rosanna Fleming; Siobhan Fogarty
Journal:  Ann Gen Psychiatry       Date:  2008-10-15       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.